Blasi F
Dipartimento di Ricerca Biologica e Tecnologica, H.S. Raffaele, Milano, Italy.
APMIS. 1999 Jan;107(1):96-101. doi: 10.1111/j.1699-0463.1999.tb01531.x.
Mice deficient for the urokinase plasminogen activator (uPA) gene are deficient in the recruitment of T cells and macrophages and succumb to bacterial infections. High levels of uPA or of its receptor (uPAR, CD87) are produced in human cancers and are strong prognostic indicators of relapse. Thus uPA and uPAR have a profound influence on cell migration. This set of molecules is known to regulate surface proteolysis, cell adhesion and chemotaxis. We have investigated the mechanism involved in uPAR-dependent chemotaxis. Chemotaxis is induced through an uPA-dependent conformational change in uPAR which uncovers a very potent chemotactic epitope acting through a pertussis-toxin sensitive step and activating intracellular tyrosine kinases. The epitope is located in the linker region between domain D1 and D2 of uPAR. Binding of uPA transforms uPAR from a receptor for uPA into a pleiotropic ligand ("activated uPAR") for other still unidentified surface molecules. Through these "adaptors", uPAR causes cytoskeletal changes, activation of kinases and directional cell migration. The conformational change can be substituted by cleavage between domain D1 and D2, in an area that can be cleaved by uPA itself at high efficiency.
尿激酶型纤溶酶原激活剂(uPA)基因缺陷的小鼠在募集T细胞和巨噬细胞方面存在缺陷,并易死于细菌感染。在人类癌症中会产生高水平的uPA或其受体(uPAR,CD87),并且是复发的强有力预后指标。因此,uPA和uPAR对细胞迁移有深远影响。已知这组分子可调节表面蛋白水解、细胞粘附和趋化作用。我们研究了uPAR依赖性趋化作用所涉及的机制。趋化作用是通过uPAR中依赖于uPA的构象变化诱导的,该变化揭示了一个非常有效的趋化表位,其作用通过百日咳毒素敏感步骤并激活细胞内酪氨酸激酶。该表位位于uPAR的D1和D2结构域之间的连接区域。uPA的结合将uPAR从uPA的受体转变为其他仍未确定的表面分子的多效性配体(“活化的uPAR”)。通过这些“衔接子”,uPAR引起细胞骨架变化、激酶激活和细胞定向迁移。这种构象变化可以通过在D1和D2结构域之间的区域进行切割来替代,该区域可被uPA自身高效切割。